miR-22 in cardiac remodeling and disease.

Regulation of gene expression during cardiac development and remodeling is very complicated, involving epigenetic, transcriptional, post-transcriptional, and translational regulation. Our understanding of the molecular mechanisms underlying cardiac remodeling is still far from complete. MicroRNAs are a class of small non-coding RNAs that have been shown to play critical roles in gene regulation in cardiovascular biology and disease. microRNA-22 (miR-22) is an evolutionally conserved miRNA that is highly expressed in the heart. Recent studies uncovered miR-22 as an important regulator for cardiac remodeling. miR-22 modulates the expression and function of genes involved in hypertrophic response, sarcomere reorganization, and metabolic program shift during cardiac remodeling. In this review, we will focus on the recent findings of miR-22 in cardiac remodeling and the therapeutic potential of this miRNA in the treatment of related defects resulting from adverse cardiac remodeling.

[1]  Anton J. Enright,et al.  Targeted Deletion of MicroRNA-22 Promotes Stress-Induced Cardiac Dilation and Contractile Dysfunction , 2012, Circulation.

[2]  Ju-hui Qiu,et al.  Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3 , 2012, Journal of Cancer Research and Clinical Oncology.

[3]  Xiaoxia Qi,et al.  Gene Expression by a MicroRNA Control of Stress-Dependent Cardiac Growth , 2008 .

[4]  Offer Amir,et al.  Serum levels of microRNAs in patients with heart failure , 2012, European journal of heart failure.

[5]  Thomas Thum,et al.  MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart , 2012, AGE.

[6]  T. Thum,et al.  A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. , 2012, Journal of molecular and cellular cardiology.

[7]  T. Ozcelik,et al.  Neuro-ophthalmologic findings in humans with quadrupedal locomotion , 2012, Ophthalmic genetics.

[8]  C. Abreu-Goodger,et al.  microRNA-22 Promotes Heart Failure through Coordinate Suppression of PPAR/ERR-Nuclear Hormone Receptor Transcription , 2013, PloS one.

[9]  Da-Zhi Wang,et al.  The Emerging Role of MicroRNAs as a Therapeutic Target for Cardiovascular Disease , 2010, BioDrugs.

[10]  B. Reinhart,et al.  MicroRNAs in plants. , 2002, Genes & development.

[11]  Konstantinos N. Malizos,et al.  Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks , 2008, PloS one.

[12]  L. Bu,et al.  MicroRNA-22 Downregulation by Atorvastatin in a Mouse Model of Cardiac Hypertrophy: a new Mechanism for Antihypertrophic Intervention , 2013, Cellular Physiology and Biochemistry.

[13]  V. Ambros,et al.  An Extensive Class of Small RNAs in Caenorhabditis elegans , 2001, Science.

[14]  V. Kim,et al.  Biogenesis of small RNAs in animals , 2009, Nature Reviews Molecular Cell Biology.

[15]  J. Huss,et al.  Nuclear receptor signaling and cardiac energetics. , 2004, Circulation research.

[16]  Ugo Ala,et al.  MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling , 2013, Cell.

[17]  E. Olson,et al.  MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles , 2012, Nature Reviews Drug Discovery.

[18]  Jian-Fu Chen,et al.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. , 2007, Journal of molecular and cellular cardiology.

[19]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[20]  E. Olson,et al.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.

[21]  M. Yamakuchi,et al.  MicroRNA-22 Regulates Hypoxia Signaling in Colon Cancer Cells , 2011, PloS one.

[22]  T. Tuschl,et al.  Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.

[23]  Antony Rodriguez,et al.  Common Variation Neighbouring Micro-RNA 22 Is Associated with Increased Left Ventricular Mass , 2013, PloS one.

[24]  Yuan Zhang,et al.  Multiple Tumor-Associated MicroRNAs Modulate the Survival and Longevity of Dendritic Cells by Targeting YWHAZ and Bcl2 Signaling Pathways , 2013, The Journal of Immunology.

[25]  J. Amiel,et al.  miRNA, development and disease. , 2012, Advances in genetics.

[26]  Sha Huang,et al.  Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. , 2012, Stem cells and development.

[27]  Chen Wu,et al.  An estrogen receptor α suppressor, microRNA‐22, is downregulated in estrogen receptor α‐positive human breast cancer cell lines and clinical samples , 2010, The FEBS journal.

[28]  Tian Yang,et al.  microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity , 2010, British Journal of Cancer.

[29]  Jian-Fu Chen,et al.  MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. , 2009, The Journal of clinical investigation.

[30]  E. Olson,et al.  Cardiac plasticity. , 2008, The New England journal of medicine.

[31]  Zicai Liang,et al.  Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein , 2010, Oncogene.

[32]  Qing Jing,et al.  Attenuation of MicroRNA‐22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy , 2012, Journal of cellular physiology.

[33]  S Badve,et al.  Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22 , 2011, Oncogene.

[34]  L. Bu,et al.  In vitro and in vivo direct monitoring of miRNA-22 expression in isoproterenol-induced cardiac hypertrophy by bioluminescence imaging , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  L. Lim,et al.  An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.

[36]  R. Strair,et al.  Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression. , 2010, Biochemical and biophysical research communications.

[37]  Takashi Takata,et al.  miR-22 represses cancer progression by inducing cellular senescence , 2011, Journal of Cell Biology.

[38]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.

[39]  P. Pandolfi,et al.  The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. , 2013, Cell stem cell.

[40]  E. Olson,et al.  Pervasive roles of microRNAs in cardiovascular biology , 2011, Nature.

[41]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[42]  Jun Yang,et al.  MicroRNA-22 targeting CBP protects against myocardial ischemia–reperfusion injury through anti-apoptosis in rats , 2013, Molecular Biology Reports.

[43]  F. Villarroya,et al.  Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. , 2011, Cardiovascular research.

[44]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[45]  S. Watowich,et al.  miR-22 Controls Irf8 mRNA Abundance and Murine Dendritic Cell Development , 2012, PloS one.

[46]  Da-Zhi Wang,et al.  MicroRNAs in heart development. , 2012, Current topics in developmental biology.

[47]  Didier Picard,et al.  miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA , 2009, Molecular and Cellular Biology.

[48]  Antony Rodriguez,et al.  MicroRNA-22 Is a Master Regulator of Bone Morphogenetic Protein-7/6 Homeostasis in the Kidney* , 2013, The Journal of Biological Chemistry.

[49]  A. Jovičić,et al.  MicroRNA-22 (miR-22) Overexpression Is Neuroprotective via General Anti-Apoptotic Effects and May also Target Specific Huntington’s Disease-Related Mechanisms , 2013, PloS one.

[50]  Da-Zhi Wang,et al.  microRNAs in cardiovascular development. , 2012, Journal of molecular and cellular cardiology.

[51]  N. Schork,et al.  MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension. , 2013, Human molecular genetics.

[52]  H. Aburatani,et al.  Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. , 2011, Cancer research.

[53]  Peer Bork,et al.  Ancient animal microRNAs and the evolution of tissue identity , 2010, Nature.

[54]  Nadav S. Bar,et al.  miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics , 2010, PloS one.

[55]  G. Dorn,et al.  Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs , 2012, Proceedings of the National Academy of Sciences.

[56]  Martin M Matzuk,et al.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. , 2010, Molecular endocrinology.